From the Field

From Personal Loss to Professional Passion

From Personal Loss to Professional Passion: A Researcher’s Dedication to Transforming Patients’ Lives When Tycel Phillips, MD, of City of Hope, was a young child growing up in Chicago, his grandmother gave him an anatomy book as a gift. And…

Where Are They Now? John Pagel, MD, PhD

Where Are They Now? John Pagel, MD, PhD When did you become interested in the study of medicine? In lymphoma specifically? When I was a kid, I was interested in two things: sports and science! Some of my earliest memories…

Where Are They Now? Jamie Flerlage, MD, MS

Where Are They Now? Jamie Flerlage, MD, MS When did you become interested in the study of medicine? In lymphoma specifically? After realizing in high school that only 1% of astronauts went to space, I shifted my love for science…

Researcher Spotlight: Jennifer Brown, MD, PhD

For over 20 years, Dr. Brown has led teams at Dana- Farber Cancer Institute to new understandings of chronic lymphocytic leukemia (CLL) and run clinical trials that
have improved outcomes for countless patients.

Conquering the Unknowns in Lymphoma

Thomas Habermann, MD, a Professor of Medicine at Mayo Clinic in Rochester, Minnesota, and former Chair of the Lymphoma Research Foundation’s Scientific Advisory Board (SAB) brings passion and drive to every study he works on and every patient he works with.

Where Are They Now? Ryan Lynch, MD

Where Are They Now? Ryan Lynch, MD Dr. Ryan Lynch is a hematologist-oncologist at Fred Hutchinson Cancer Center. When did you become interested in the study of medicine? In lymphoma specifically? I had a great opportunity while I was in…

Breakthroughs Start with Strong Patient Relationships

Many healthcare professionals get into medicine out of a desire to help people, and Zachary Epstein-Peterson, MD is no exception. In fact, one of the primary factors that led him to focus his career on lymphoma was witnessing the close relationships between doctor and patient during his early rotations, and it’s those deep connections with patients that continue to inform his lymphoma research today.